O

ORKA

ORKA

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
ORKA Live QuoteReal-time
$97.57
+$17.65(+22.08%)1M
Day Range$96.11 – $101.94
Open$96.70
Previous Close$95.74
Volume927.1K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$6.62B
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-2.12
Price to Book5.4
Dividend Yield0.65%
Beta (Volatility)-0.17
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $97.57 (80%)
Low: $25.23High: $115.52
Wall Street Consensus
Hold
Analyst Rating
3.0/ 5.0
Target Price
$156.17+4.1% upside

Insider Buys

1

$1.41M

Insider Sales

46

$343.71M

Total Volume

$345.12M

76 transactions

Net Activity

$342.30M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
25CONFIDENCE

Sentiment Rating

Moderate Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •High accumulation: total purchase value exceeds $1M.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

S - Sale+OE Insiders

0 buys29 sells

$509.77B total

F
2

Fairmount Funds Management LLC

Dir, 10%

0 buys1 sells

$300.01M total

K
3

Klein Lawrence Otto

CEO

0 buys6 sells

$11.79M total

D
4

Dambkowski Carl

Dir

0 buys2 sells

$8.65M total

Q
5

Quinlan Paul T

GC

0 buys6 sells

$7.47M total

Trading History
ORKA insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 16, 2026

4 days ago

Goncalves Joana

Chief Medical Officer

C-Level
Sell7.0K$100.96$707K

Nov 12, 2026

1 weeks ago

Agarwal Arjun

SVP, Finance

SVP
Sell10.0K$104.97$1.05M

Nov 12, 2026

1 weeks ago

Ball Kristine M

Dir

Director
Sell18.0K$104.93$1.89M

Nov 2, 2026

2 weeks ago

Klein Lawrence Otto

CEO

CEO
Sell25.0K$95.61$2.39M

Oct 20, 2026

1 months ago

Quinlan Paul T

GC

General Counsel
Sell9.0K$78.53$707K

Oct 15, 2026

1 months ago

Goncalves Joana

Chief Medical Officer

C-Level
Sell7.0K$74.81$524K

Oct 15, 2026

1 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell31.8K$-7000.00$0

Oct 12, 2026

1 months ago

Agarwal Arjun

SVP, Finance

SVP
Sell10.0K$80.60$806K

Oct 12, 2026

1 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell14.2K$-9999.00$0

Oct 1, 2026

1 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell923.1K$-25000.00$0

Oct 1, 2026

1 months ago

Klein Lawrence Otto

CEO

CEO
Sell25.0K$83.62$2.09M

Sep 21, 2026

2 months ago

Agarwal Arjun

SVP, Finance

SVP
Sell533$95.75$51K

Sep 21, 2026

2 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell14.2K$-533.00$0

Sep 21, 2026

2 months ago

Quinlan Paul T

GC

General Counsel
Sell10.0K$93.64$936K

Sep 15, 2026

2 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell31.8K$-7947.00$0

Sep 11, 2026

2 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell14.8K$-10019.00$0

Sep 15, 2026

2 months ago

Sandler Laura Lee

COO

COO
Sell906$95.71$87K

Sep 15, 2026

2 months ago

Quinlan Paul T

GC

General Counsel
Sell1.0K$95.71$99K

Sep 15, 2026

2 months ago

Klein Lawrence Otto

CEO

CEO
Sell2.5K$95.71$235K

Sep 11, 2026

2 months ago

Agarwal Arjun

SVP, Finance

SVP
Sell10.0K$92.43$926K

Sep 15, 2026

2 months ago

Goncalves Joana

Chief Medical Officer

C-Level
Sell7.9K$92.38$734K

Sep 1, 2026

2 months ago

Sandler Laura Lee

COO

COO
Sell5.0K$91.82$459K

Sep 1, 2026

2 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell236.4K$-5000.00$0

Sep 1, 2026

2 months ago

Klein Lawrence Otto

CEO

CEO
Sell75.0K$91.83$6.89M

Aug 17, 2026

3 months ago

Goncalves Joana

Chief Medical Officer

C-Level
Sell7.0K$111.84$783K

Aug 17, 2026

3 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell32.7K$-7000.00$0

Aug 13, 2026

3 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell15.3K$-10000.00$0

Aug 13, 2026

3 months ago

Agarwal Arjun

SVP, Finance

SVP
Sell10.0K$106.66$1.07M

Aug 14, 2026

3 months ago

Quinlan Paul T

GC

General Counsel
Sell52.0K$108.49$5.64M

Aug 14, 2026

3 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell31.0K$-52000.00$0

Jul 15, 2026

4 months ago

Goncalves Joana

Chief Medical Officer

C-Level
Sell7.0K$86.28$604K

Jul 15, 2026

4 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell32.7K$-7000.00$0

Jul 13, 2026

4 months ago

Agarwal Arjun

SVP, Finance

SVP
Sell10.0K$84.63$846K

Jul 13, 2026

4 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell15.3K$-9999.00$0

Jul 1, 2026

4 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell3.71M$-3553410.00$0

Jul 1, 2026

4 months ago

Fairmount Funds Management LLC

Dir, 10%

Director
Sell3.55M$84.43$300.01M

Jul 1, 2026

4 months ago

Sandler Laura Lee

COO

COO
Sell5.0K$94.42$472K

Jun 22, 2026

5 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell15.3K$-1587.00$0

Jun 22, 2026

5 months ago

Agarwal Arjun

SVP, Finance

SVP
Sell1.6K$80.95$128K

Jun 15, 2026

5 months ago

Quinlan Paul T

GC

General Counsel
Sell733$69.69$51K

Jun 15, 2026

5 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell32.7K$-7947.00$0

Jun 12, 2026

5 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell16.9K$-9854.00$0

Jun 12, 2026

5 months ago

Agarwal Arjun

SVP, Finance

SVP
Sell9.9K$69.72$687K

Jun 15, 2026

5 months ago

Goncalves Joana

Chief Medical Officer

C-Level
Sell7.9K$69.28$551K

Jun 15, 2026

5 months ago

Klein Lawrence Otto

CEO

CEO
Sell1.7K$69.69$120K

Jun 15, 2026

5 months ago

Sandler Laura Lee

COO

COO
Sell600$69.69$42K

Jun 11, 2026

5 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell38.7K$-35000.00$0

Jun 11, 2026

5 months ago

Dambkowski Carl

Dir

Director
Sell35.0K$70.13$2.45M

May 21, 2026

6 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell73.7K$-105000.00$0

May 21, 2026

6 months ago

Dambkowski Carl

Dir

Director
Sell105.0K$58.97$6.19M

May 18, 2026

6 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell16.4K$-10290.00$0

May 18, 2026

6 months ago

Agarwal Arjun

SVP, Finance

SVP
Sell10.3K$59.07$608K

May 15, 2026

6 months ago

Goncalves Joana

Chief Medical Officer

C-Level
Sell7.0K$61.85$433K

May 15, 2026

6 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell33.4K$-7000.00$0

May 1, 2026

6 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell237.0K$-5000.00$0

May 1, 2026

6 months ago

Sandler Laura Lee

COO

COO
Sell5.0K$63.88$319K

Apr 15, 2026

7 months ago

Goncalves Joana

Chief Medical Officer

C-Level
Sell7.0K$66.12$463K

Apr 15, 2026

7 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell33.4K$-7000.00$0

Mar 16, 2026

8 months ago

Quinlan Paul T

GC

General Counsel
Sell733$41.30$30K

Mar 16, 2026

8 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell927.3K$-1729.00$0

Mar 16, 2026

8 months ago

Klein Lawrence Otto

CEO

CEO
Sell1.7K$41.30$71K

Mar 16, 2026

8 months ago

Agarwal Arjun

SVP, Finance

SVP
Sell395$41.30$16K

Mar 16, 2026

8 months ago

Sandler Laura Lee

COO

COO
Sell600$41.30$25K

Mar 16, 2026

8 months ago

Goncalves Joana

Chief Medical Officer

C-Level
Sell7.6K$40.91$313K

Mar 2, 2026

8 months ago

Sandler Laura Lee

COO

COO
Sell5.0K$33.56$168K

Mar 2, 2026

8 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell237.6K$-5000.00$0

Feb 17, 2026

9 months ago

Goncalves Joana

Chief Medical Officer

C-Level
Sell7.0K$32.37$227K

Feb 17, 2026

9 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell34.0K$-7000.00$0

Jan 15, 2026

10 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell1.5K$-7000.00$0

Jan 15, 2026

10 months ago

Goncalves Joana

Chief Medical Officer

C-Level
Sell7.0K$31.81$223K

Jan 2, 2026

10 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell205.1K$-13000.00$0

Jan 2, 2026

10 months ago

Sandler Laura Lee

COO

COO
Sell13.0K$28.52$371K

Dec 19, 2025

11 months ago

Goncalves Joana

Chief Medical Officer

C-Level
Sell7.0K$30.61$214K

Dec 19, 2025

11 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell1.5K$-7000.00$0

Feb 10, 2025

21 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell4.15M$122882.00$509.77B

Feb 10, 2025

21 months ago

Venrock Healthcare Capital Partners Iii, L.P.

10%

10% Owner
Buy122.9K$11.45$1.41M
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
ORKA Buy Conviction0%
Industry Rank#178 of 569
Volume Contribution2.1%
Total Industry Activity$16.52B

ORKA has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. ORKA ranks #178 in insider activity out of 569 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for ORKA

Over the last 90 days, corporate insiders at ORKA (ORKA) engaged in a total of 76 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 46 were sales. The total volume of insider trading reached $345.12M.

The net insider activity for ORKA shows a net selling bias of $342.30M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 4.15M shares valued at $509.77B on Feb 10, 2025.

Live Market News & Developments
Aggregated real-time headlines for ORKA (ORKA)
6 updates

ORKA Stock Up More Than 60% in 3 Months: Here's What You Should Know

Yahoo Finance84d ago

ORKA - Oruka Therapeutics Inc Stock Price and Quote

Finviz178d ago

Jefferies reiterates Buy on Oruka Therapeutics stock ahead of data

Investing.com UKYesterday

In a psoriasis trial, 71% had clear skin six months after their last dose

Stock Titan58d ago

What Oruka Therapeutics (ORKA)'s Phase 2a Psoriasis Data Means For Shareholders

Yahoo Finance58d ago

Fund Update: New $6.5M $ORKA stock position opened by Fisher Asset Management, LLC

Quiver Quantitative108d ago

FAQs About ORKA Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for ORKA.

Based on SEC Form 4 disclosures, the Insider Confidence Score for ORKA is currently 25/100, which reflects a moderate distribution bias. This calculation accounts for a total of 1 purchases and 46 sales by company executives over the last 90 days.

The CEO Conviction Index for ORKA is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.